172 related articles for article (PubMed ID: 22747744)
21. Evaluation of (R)-[11C]verapamil as PET tracer of P-glycoprotein function in the blood-brain barrier: kinetics and metabolism in the rat.
Luurtsema G; Molthoff CF; Schuit RC; Windhorst AD; Lammertsma AA; Franssen EJ
Nucl Med Biol; 2005 Jan; 32(1):87-93. PubMed ID: 15691665
[TBL] [Abstract][Full Text] [Related]
22. Assessment of cerebral P-glycoprotein expression and function with PET by combined [11C]inhibitor and [11C]substrate scans in rats.
Müllauer J; Karch R; Bankstahl JP; Bankstahl M; Stanek J; Wanek T; Mairinger S; Müller M; Löscher W; Langer O; Kuntner C
Nucl Med Biol; 2013 Aug; 40(6):755-63. PubMed ID: 23774004
[TBL] [Abstract][Full Text] [Related]
23. A comparative small-animal PET evaluation of [11C]tariquidar, [11C]elacridar and (R)-[11C]verapamil for detection of P-glycoprotein-expressing murine breast cancer.
Wanek T; Kuntner C; Bankstahl JP; Bankstahl M; Stanek J; Sauberer M; Mairinger S; Strommer S; Wacheck V; Löscher W; Erker T; Müller M; Langer O
Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):149-59. PubMed ID: 21983837
[TBL] [Abstract][Full Text] [Related]
24. (R)-[¹¹C]Emopamil as a novel tracer for imaging enhanced P-glycoprotein function.
Toyohara J; Okamoto M; Aramaki H; Zaitsu Y; Shimizu I; Ishiwata K
Nucl Med Biol; 2016 Jan; 43(1):52-62. PubMed ID: 26429767
[TBL] [Abstract][Full Text] [Related]
25. 11C-loperamide and its N-desmethyl radiometabolite are avid substrates for brain permeability-glycoprotein efflux.
Zoghbi SS; Liow JS; Yasuno F; Hong J; Tuan E; Lazarova N; Gladding RL; Pike VW; Innis RB
J Nucl Med; 2008 Apr; 49(4):649-56. PubMed ID: 18344435
[TBL] [Abstract][Full Text] [Related]
26. Head-to-head comparison of (R)-[
García-Varela L; Vállez García D; Aguiar P; Kakiuchi T; Ohba H; Harada N; Nishiyama S; Tago T; Elsinga PH; Tsukada H; Colabufo NA; Dierckx RAJO; van Waarde A; Toyohara J; Boellaard R; Luurtsema G
Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4307-4317. PubMed ID: 34117508
[TBL] [Abstract][Full Text] [Related]
27. A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier.
Hendrikse NH; de Vries EG; Eriks-Fluks L; van der Graaf WT; Hospers GA; Willemsen AT; Vaalburg W; Franssen EJ
Cancer Res; 1999 May; 59(10):2411-6. PubMed ID: 10344751
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of [11C]XR9576 to assess the function of drug efflux transporters using PET.
Kawamura K; Konno F; Yui J; Yamasaki T; Hatori A; Yanamoto K; Wakizaka H; Takei M; Nengaki N; Fukumura T; Zhang MR
Ann Nucl Med; 2010 Jun; 24(5):403-12. PubMed ID: 20361276
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and preclinical evaluation of novel PET probes for P-glycoprotein function and expression.
van Waarde A; Ramakrishnan NK; Rybczynska AA; Elsinga PH; Berardi F; de Jong JR; Kwizera C; Perrone R; Cantore M; Sijbesma JW; Dierckx RA; Colabufo NA
J Med Chem; 2009 Jul; 52(14):4524-32. PubMed ID: 19530699
[TBL] [Abstract][Full Text] [Related]
30. (R)- and (S)-[11C]verapamil as PET-tracers for measuring P-glycoprotein function: in vitro and in vivo evaluation.
Luurtsema G; Molthoff CF; Windhorst AD; Smit JW; Keizer H; Boellaard R; Lammertsma AA; Franssen EJ
Nucl Med Biol; 2003 Oct; 30(7):747-51. PubMed ID: 14499333
[TBL] [Abstract][Full Text] [Related]
31. Modeling cyclosporine A inhibition of the distribution of a P-glycoprotein PET ligand, 11C-verapamil, into the maternal brain and fetal liver of the pregnant nonhuman primate: impact of tissue blood flow and site of inhibition.
Ke AB; Eyal S; Chung FS; Link JM; Mankoff DA; Muzi M; Unadkat JD
J Nucl Med; 2013 Mar; 54(3):437-46. PubMed ID: 23359659
[TBL] [Abstract][Full Text] [Related]
32. Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography.
Sasongko L; Link JM; Muzi M; Mankoff DA; Yang X; Collier AC; Shoner SC; Unadkat JD
Clin Pharmacol Ther; 2005 Jun; 77(6):503-14. PubMed ID: 15961982
[TBL] [Abstract][Full Text] [Related]
33. Study on in situ and in vivo absorption kinetics of phenytoin by modulating P-glycoprotein with verapamil in rats.
Neerati P; Ganji D; Bedada SK
Eur J Pharm Sci; 2011 Sep; 44(1-2):27-31. PubMed ID: 21640186
[TBL] [Abstract][Full Text] [Related]
34. Altered GABAA receptor density and unaltered blood-brain barrier transport in a kainate model of epilepsy: an in vivo study using 11C-flumazenil and PET.
Syvänen S; Labots M; Tagawa Y; Eriksson J; Windhorst AD; Lammertsma AA; de Lange EC; Voskuyl RA
J Nucl Med; 2012 Dec; 53(12):1974-83. PubMed ID: 23143088
[TBL] [Abstract][Full Text] [Related]
35. Complete in vivo reversal of P-glycoprotein pump function in the blood-brain barrier visualized with positron emission tomography.
Hendrikse NH; Schinkel AH; de Vries EG; Fluks E; Van der Graaf WT; Willemsen AT; Vaalburg W; Franssen EJ
Br J Pharmacol; 1998 Aug; 124(7):1413-8. PubMed ID: 9723952
[TBL] [Abstract][Full Text] [Related]
36. Dissimilar Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Distribution of Erlotinib to the Retina and Brain in Humans and Mice.
Biali ME; Auvity S; Cisternino S; Smirnova M; Hacker M; Zeitlinger M; Mairinger S; Tournier N; Bauer M; Langer O
Mol Pharm; 2023 Nov; 20(11):5877-5887. PubMed ID: 37883694
[TBL] [Abstract][Full Text] [Related]
37. New positron emission tomography tracer [(11)C]carvedilol reveals P-glycoprotein modulation kinetics.
Bart J; Dijkers EC; Wegman TD; de Vries EG; van der Graaf WT; Groen HJ; Vaalburg W; Willemsen AT; Hendrikse NH
Br J Pharmacol; 2005 Aug; 145(8):1045-51. PubMed ID: 15951832
[TBL] [Abstract][Full Text] [Related]
38. Dose-response assessment of cerebral P-glycoprotein inhibition in vivo with [
Garcia-Varela L; Mossel P; Aguiar P; Vazquez-Matias DA; van Waarde A; Willemsen ATM; Bartels AL; Colabufo NA; Dierckx RAJO; Elsinga PH; Luurtsema G
J Control Release; 2022 Jul; 347():500-507. PubMed ID: 35588934
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and in vivo evaluation of [11C]tariquidar, a positron emission tomography radiotracer based on a third-generation P-glycoprotein inhibitor.
Bauer F; Kuntner C; Bankstahl JP; Wanek T; Bankstahl M; Stanek J; Mairinger S; Dörner B; Löscher W; Müller M; Erker T; Langer O
Bioorg Med Chem; 2010 Aug; 18(15):5489-97. PubMed ID: 20621487
[TBL] [Abstract][Full Text] [Related]
40. Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodents.
Terry G; Liow JS; Chernet E; Zoghbi SS; Phebus L; Felder CC; Tauscher J; Schaus JM; Pike VW; Halldin C; Innis RB
Neuroimage; 2008 Jul; 41(3):690-8. PubMed ID: 18456516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
